Bictegravir is an antiviral medication used in combination with other medicines to treat HIV-1 infection in adults and children 12 years of age and older. It is used in combination with emtricitabine and tenofovir alafenamide (Descovy) or emtricitabine and tenofovir disoproxil fumarate (Truvada). Bictegravir is an integrase strand transfer inhibitor (INSTI) that works by blocking an enzyme (integrase) needed for HIV to multiply and spread in the body.
Bictegravir is a medication used to treat HIV infection. It is a second-generation integrase inhibitor, which works by blocking the HIV virus from integrating its genetic material into the genetic material of human T cells. This prevents the virus from replicating and spreading in the body.
Bictegravir is typically used in combination with other antiretroviral medications. It is available in a single-tablet regimen that also includes emtricitabine and tenofovir alafenamide. This combination is known by the brand name Biktarvy.
Bictegravir is a generally well-tolerated medication. However, it can cause some side effects, such as headache, diarrhea, nausea, and fatigue. It is important to talk to your doctor about the potential risks and benefits of taking bictegravir before starting treatment.
Here are some additional things to know about bictegravir:
- It is not a cure for HIV infection.
- It does not prevent the transmission of HIV to others.
- It is important to take bictegravir exactly as prescribed by your doctor.
- You should not stop taking bictegravir without talking to your doctor first.